RPID
RAPID MICRO BIOSYSTEMS, INC.
NASDAQ · Healthcare · Medical - Devices · US
$1.12
+2.75%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$1.11
From 52W high−76.07%
Volume711291.00
Market cap$56.18M
P/E (TTM)—
P/S (TTM)1.6x
Div yield—
Key dataSep 18, 2026
Open
$1.11
From 52W high
−76.07%
Volume
711291.00
Market cap
$56.18M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.3x
P/E (TTM)
—
RSI (14)
30.3
MomentumView details →
1D Return
+2.75%
YTD Return
−59.10%
SummaryUpdated Jun 1, 2026
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) is a life sciences technology company founded in 2006 and headquartered in Lowell, Massachusetts. Originally incorporated as Genomic Profiling Systems, Inc., the company changed its name to Rapid Micro Biosystems in January 2007 and went public in July 2021. The company specializes in automating microbial quality control testing for pharmaceutical, medical device, and personal care manufacturers through its flagship Growth Direct platform, which modernizes traditional manual testing workflows that have remained largely unchanged for decades.
Similar companies
Latest newsMore news →